{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:50:41Z","timestamp":1780325441689,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/beha.2002.0226","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T18:13:53Z","timestamp":1046801633000},"page":"729-740","source":"Crossref","is-referenced-by-count":12,"title":["New treatment strategies in childhood acute lymphoblastic leukaemia"],"prefix":"10.1053","volume":"15","author":[{"given":"Martin","family":"Schrappe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"B\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0226_RF1","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","article-title":"Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86","volume":"84","author":"Reiter","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.1994.12.4.740","article-title":"Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute\/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85\u201301","volume":"12","author":"Schorin","year":"1994","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0226_RF3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","article-title":"Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X","volume":"345","author":"Chessells","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0226_RF4","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","article-title":"Childhood leukemias","volume":"332","author":"Pui","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0226_RF5","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy","volume":"338","author":"Nachman","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0226_RF6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.leu.2401973","article-title":"Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995","volume":"14","author":"Schrappe","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0226_RF7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-3-642-74643-7_81","article-title":"Results and significance of six randomized trials in four consecutive ALL-BFM trials","volume":"33","author":"Riehm","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1053\/beha.2002.0226_RF8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1993.11.3.527","article-title":"Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children's Cancer Group phase III trial","volume":"11","author":"Tubergen","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0226_RF9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1005903414734","article-title":"Prophylaxis and treatment of meningeosis in childhood acute lymphoblastic leukemia","volume":"38","author":"Schrappe","year":"1998","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1053\/beha.2002.0226_RF10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","article-title":"Die Corticosteroid-abh\u00e4ngige Dezimierung der Leuk\u00e4miezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leuk\u00e4mie im Kindesalter (Therapiestudie ALL-BFM 83). [The in vivo response on corticosteriod therapy as an additional prognostic factor in childhood acute lymphoblastic leukemia (therapy study ALL-BFM 83).]","volume":"199","author":"Riehm","year":"1987","journal-title":"Klinische P\u00e4diatrie"},{"key":"10.1053\/beha.2002.0226_RF11","first-page":"3310","article-title":"Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: results of trial ALL-BFM 90","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292","article-title":"Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia","volume":"86","author":"Gajjar","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1996.14.2.389","article-title":"Cytoreduction and prognosis in acute lymphoblastic leukemia \u2013 the importance of early marrow response: report from the Childrens Cancer Group","volume":"14","author":"Steinherz","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0226_RF14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","article-title":"Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review","volume":"80","author":"Gaynon","year":"1997","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0226_RF15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia","volume":"351","author":"Coustan-Smith","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0226_RF16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia: a prospective study of the International BFM Study Group","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0226_RF17","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/sj.leu.2401922","article-title":"Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group","volume":"14","author":"Biondi","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0226_RF18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V95.3.790.003k48_790_794","article-title":"Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia","volume":"95","author":"Panzer-Grumayer","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.leu.2402019","article-title":"MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen","volume":"15","author":"zur Stadt","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0226_RF20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","article-title":"Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome","volume":"99","author":"Nyvold","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0226_RF22","first-page":"957","article-title":"Incidence and clinical outcome of children with BCR\/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM 90 and CoALL-05-92","volume":"10","author":"Schlieben","year":"1996","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0226_RF23","first-page":"718a","article-title":"Improved risk-adapted treatment of childhood ALL with a new stratification system based on early response, genetics, age, and WBC: first interim analysis of trial ALL-BFM 95","volume":"98","author":"Schrappe","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.V100.2.420","article-title":"Improved outcome in high risk childhood acute lymphoblastic leukemia defined by prednisone poor response treated with double BFM Protocol II","volume":"100","author":"Aric\u00f2","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF25","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/sj.leu.2400841","article-title":"Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response","volume":"11","author":"Foroni","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0226_RF26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.leu.2400643","article-title":"T cell receptor Ddelta2Ddelta3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"11","author":"Seriu","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0226_RF27","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","article-title":"Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL","volume":"99","author":"Willemse","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"339","author":"Cave","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0226_RF29","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","article-title":"Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia","volume":"99","author":"Dworzak","year":"2002","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF30","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1200\/JCO.1993.11.11.2234","article-title":"Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106","volume":"11","author":"Gaynon","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0226_RF31","first-page":"299","article-title":"The Berlin childhood acute lymphoblastic leukemia therapy study, 1970\u20131976","volume":"2","author":"Riehm","year":"1980","journal-title":"American Journal of Pediatric Hematology and Oncology"},{"key":"10.1053\/beha.2002.0226_RF32","first-page":"416","article-title":"Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF33","first-page":"2730","article-title":"Ph+ childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome","volume":"92","author":"Schrappe","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF34","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome- positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0226_RF35","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0226_RF36","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.1996.14.10.2812","article-title":"Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome","volume":"14","author":"B\u00fchrer","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0226_RF37","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(01)06355-3","article-title":"Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia","volume":"358","author":"Eckert","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0226_RF38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2141.1995.tb03313.x","article-title":"Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials","volume":"89","author":"Chessells","year":"1995","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0226_RF39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mpo.2950180403","article-title":"Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features","volume":"18","author":"Gaynon","year":"1990","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0226_RF40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"Doerdelmann","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF41","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V80.10.2471.2471","article-title":"Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group","volume":"80","author":"Reiter","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF42","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0226_RF43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-3-642-74643-7_83","article-title":"More is better! Update of Dana-Farber Cancer Institute\/Children's Hospital childhood acute lymphoblastic leukemia trials","volume":"33","author":"Sallan","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1053\/beha.2002.0226_RF44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0140-6736(91)90733-6","article-title":"Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy","volume":"337","author":"Rivera","year":"1991","journal-title":"Lancet"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T19:49:24Z","timestamp":1584474564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602902264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521692602902264"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0226","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}